Centrus Energy Corp.
LEU
$102.45
-1.63%
Centrus Energy Corp. supplies nuclear fuel and related technical services to the nuclear power industry, operating through a Low-Enriched Uranium (LEU) segment that sells separative work units and uranium, and a Technical Solutions segment providing engineering, design, and manufacturing services to government and private customers, with the vast majority of revenue generated in the United States. The company occupies a uniquely strategic niche as the only Western (and specifically U.S.-licensed) producer of high-assay low-enriched uranium (HALEU), giving it a near-monopoly position in the fuel supply chain that advanced nuclear reactor developers depend on, a distinction reinforced by its roughly 467-employee footprint and government-backed contract base. The current investor narrative centers on Centrus as a pure-play beneficiary of the AI-driven nuclear power buildout, with headlines highlighting a landmark HALEU supply agreement with Antares Nuclear, a long-term fuel supply deal with Oklo, a reported $3.9 billion backlog, and a roughly $900 million government contract. At the same time, the debate has turned sharply two-sided: bulls point to monopoly-like positioning and structural uranium supply deficits, while skeptics flag negative free cash flow, an overhyped rally tied to tangential news such as the Vistra DOE loan, and the looming expiration of legacy Russian enrichment contracts as key execution and valuation risks.…
LEU
Centrus Energy Corp.
$102.45
Related headlines
LEU 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Centrus Energy Corp.'s 12-month outlook, with a consensus price target around $225.15 and implied upside of +119.8% versus the current price.
Average Target
$225.15
0 analysts
Implied Upside
+119.8%
vs. current price
Analyst Count
—
covering this stock
Price Range
$115 - $337
Analyst target range
Drowning in data?
Find the real signal!
Bulls vs Bears: LEU Investment Factors
The bear case currently has stronger near-term evidence: the stock is in a violent downtrend (-72.3% over one year, -57.8% YTD), free cash flow is deeply negative at -$222.1 million, and valuation multiples (56x trailing PE, 33x EV/EBITDA) remain rich for a company with volatile margins and a 26.2% gross margin. The bull case rests on a genuinely unique strategic asset — the only Western HALEU producer with a $3.9 billion backlog and $900 million government contract — and an analyst consensus target of $240.82 that implies massive upside. The single most important tension is whether Centrus can convert its contracted backlog into positive free cash flow before dilution and the Russian contract expiration erode the equity story; resolution of that cash-flow question, not demand, will determine the stock's direction.
Bullish
- Only Western HALEU producer: Centrus is the only U.S.-licensed producer of high-assay low-enriched uranium, a near-monopoly position reinforced by a landmark HALEU supply agreement with Antares Nuclear and a long-term fuel supply deal with Oklo. Advanced reactor developers have few alternative Western suppliers, giving Centrus pricing power and strategic leverage in the fuel chain.
- Large contracted backlog: The company reports a roughly $3.9 billion backlog alongside a roughly $900 million government contract, which provides multi-year revenue visibility far exceeding the $636.8 million average analyst revenue estimate for the current year. This contracted base de-risks the demand side of the thesis even as execution remains uncertain.
- Revenue growth and profitability: Q2 2026 revenue of $176.1 million grew 13.98% year over year, with net income of $16.8 million (9.5% net margin) and gross margin of 28.3%. Trailing net margin is 17.3% and ROE is 10.2%, showing the core LEU business can generate accounting profits.
- Strong balance sheet liquidity: The current ratio of 5.59 indicates ample short-term liquidity to fund HALEU capacity buildout and working capital. Debt-to-equity of 1.59 is elevated but manageable given the cash position and government-backed contract base.
Bearish
- Severe price collapse and downtrend: The stock is down 72.3% over one year, 57.8% YTD, and 17.3% in the past month, closing at $114.94 versus a 52-week high of $411.51. Relative strength versus the S&P 500 is -87.9% over one year, indicating persistent institutional distribution rather than a temporary dip.
- Negative free cash flow: TTM free cash flow is -$222.1 million against a $4.36 billion market cap, and the price-to-cash-flow ratio of 85.5 is meaningless on negative cash generation. The HALEU buildout is consuming cash faster than operations produce it, creating dilution or financing risk.
- Extreme valuation on earnings: Trailing PE is 56.1x, forward PE 30.6x, EV/EBITDA 33.0x, and price-to-sales 9.72x for a company with a 26.2% gross margin and 11.2% operating margin. The PEG ratio of -15.7 reflects negative earnings growth expectations, meaning the market is paying a premium for a story rather than current fundamentals.
- Earnings volatility and margin compression: Quarterly EPS swung from $1.60 in Q1 2025 to -$0.30 in Q3 2024 and $0.85 in Q2 2026, while gross margin fell from 45.0% in Q1 2025 to 28.3% in Q2 2026. Q3 2025 actually posted negative gross profit of -$4.3 million, showing the business is not yet a stable compounder.
LEU Technical Analysis
Beta
1.54
1.54x market volatility
Max Drawdown
-76.5%
Largest decline past year
52-Week Range
$99-$402
Price range past year
Annual Return
-70.2%
Cumulative gain past year
| Period | LEU Return | S&P 500 |
|---|---|---|
| 1m | -32.3% | -1.0% |
| 3m | -37.5% | +2.9% |
| 6m | -50.2% | +6.5% |
| 1y | -70.2% | +13.1% |
| ytd | -62.4% | +11.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
LEU Fundamental Analysis
Quarterly Revenue
$176100000.0B
2026-06
Revenue YoY Growth
+14.0%
YoY Comparison
Gross Margin
28.3%
Latest Quarter
Free Cash Flow
$-222100000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is LEU Overvalued?
PE
56.1x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 1x~65x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
33.0x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are substantial. TTM free cash flow is -$222.1 million, meaning the HALEU enrichment buildout is burning cash well in excess of operating generation, and the company has funded this partly through dilution — diluted shares rose from 16.7 million in Q4 2024 to 21.9 million in Q2 2026, roughly 30%. Gross margin has compressed from 45.0% in Q1 2025 to 28.3% in Q2 2026, and Q3 2025 posted a negative gross profit of -$4.3 million, showing earnings are highly sensitive to contract timing and mix. Debt-to-equity of 1.59 adds leverage to an already volatile earnings stream, and the expiration of legacy Russian enrichment contracts removes a low-cost supply input that has historically supported margins.
Market and competitive risks center on valuation compression. At 56.1x trailing earnings, 30.6x forward earnings, 33.0x EV/EBITDA, and 9.72x sales, LEU trades at a steep premium to the broader energy sector, leaving little room for execution missteps. Beta of 1.536 means the stock amplifies market moves, and the one-year relative strength of -87.9% versus the S&P 500 shows how violently sentiment has reversed. Recent news highlights the fragility of the narrative: a rally tied to the Vistra DOE loan was criticized as overdone because there is no evidence Vistra is a customer, and skeptics flag negative free cash flow and overvaluation. Competitive threats include foreign enrichment suppliers and potential new Western HALEU entrants, while regulatory dependence on DOE funding and licensing timelines adds policy risk.
In a worst-case scenario, HALEU capacity milestones slip, the Russian contract expiration raises costs faster than new contracts price in, and the company raises equity at depressed prices to fund the cash burn. That combination could drive the stock toward its 52-week low of $112.61, essentially flat to the current $114.94, and a break below that level toward the analyst low target of $167 is not the floor — the stock has already fallen 72.1% from its $411.51 high, and the historical max drawdown of -73.64% shows losses of this magnitude are not hypothetical. From the current price, a retest of the 52-week low implies roughly -2%, but a continuation of the existing drawdown pattern toward the $80-$90 range would represent a further -22% to -30% loss for holders.